Discovery of Dengue Virus NS4B Inhibitors

Discovery of Dengue Virus NS4B Inhibitors

The four serotypes of dengue virus (DENV-1 to -4) represent the most prevalent mosquito-borne viral pathogens in humans. No clinically approved vaccine or antiviral is currently available for DENV. Here we report a spiropyrazolopyridone compound that potently inhibits DENV both in vitro and in vivo....

Full description

Bibliographic Details
Main Authors: Wang, Qing-Yin, Dong, Hongping, Zou, Bin, Karuna, Ratna, Wan, Kah Fei, Zou, Jing, Susila, Agatha, Yip, Andy, Shan, Chao, Yeo, Kim Long, Xu, Haoying, Ding, Mei, Chan, Wai Ling, Gu, Feng, Seah, Peck Gee, Liu, Wei, Lakshminarayana, Suresh B., Kang, CongBao, Lescar, Julien, Blasco, Francesca, Smith, Paul W., Shi, Pei-Yong
Other Authors: Diamond, M. S.
Format: Journal Article
Language:English
Published: 2015
Online Access:https://hdl.handle.net/10356/103770
http://hdl.handle.net/10220/38794

Internet

https://hdl.handle.net/10356/103770
http://hdl.handle.net/10220/38794

Similar Items